InSightec's long-time Neuro Program Manager has been appointed GM
From the December issue of HCB News magazine
RSNA releases details on Gadolinium-based magnetic resonance imaging (MRI) contrast agents; may be dangerous to patients with advanced kidney disease.
Expanded applications of ZEISS INTRABEAM receive approval in USA, Europe and China.
With Abu Dhabi Proton Centre, proliferation of treatment rolls on
Former senior vice president at GlaxoSmithKline appointed chief medical officer of PureTech Health
Will begin with CT algorithm to assess risk of Osteoporosis
A call for renewed entrepreneurship and funding for cardiovascular innovation
Global advancements change the health care paradigm
Checking in with the rapid evolution of stent technology
Simon Beaulah, Linguamatics’ senior director of healthcare, on how natural language processing can improve care
Turning big data into smart data
Progress in bringing predictive analytics to the care continuum
“Ugh, having an MRI is like being inside a pissed-off fax machine!”
Another salvo has been fired in the ongoing debate about routine mammography screening
From the November issue of HCB News magazine
September was a busy month in our nation's capital
Expected to hit $3 billion by 2019
To err is human, and errors in patient safety are unacceptable
An important discovery in the search for autism biomarkers
